Showing results (2821-2830 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|February 18, 2009
Wound healing delay after central venous access following DCF/VEGF-trap therapyCharles Ferté, Christophe Massard, Christian Moldovan, et al.
Investigational New Drugs|February 10, 2009
Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agentsAnthe S Zandvliet, Mats O Karlsson, Jan H M Schellens, et al.
Investigational New Drugs|November 1, 1990
A semi-automated neutral red based chemosensitivity assay for drug screeningP F Cavanaugh, P S Moskwa, W H Donish, et al.
Investigational New Drugs|November 1, 1990
Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, M D Adelson, et al.
Investigational New Drugs|November 1, 1990
Phase II trial of Didemnin B in patients with advanced renal cell carcinomaR Motzer, H Scher, D Bajorin, et al.
Investigational New Drugs|November 1, 1990
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II studyR P Castleberry, A H Ragab, C P Steuber, et al.
Investigational New Drugs|March 19, 2011
Cell cycle arrest through inhibition of tubulin polymerization by withaphysalin F, a bioactive compound isolated from Acnistus arborescensDanilo D Rocha, Aruna Balgi, Ana Isabel V Maia, et al.
Investigational New Drugs|August 1, 1990
Phase II trial of menogaril as initial chemotherapy for metastatic breast cancerM J Kennedy, R C Donehower, L B Grochow, et al.
Investigational New Drugs|March 16, 2011
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational researchDo-Youn Oh, Keun Wook Lee, Kyung-Hee Lee, et al.
Investigational New Drugs|February 1, 1990
Phase I study of oral menogaril administered on a once weekly scheduleD J Stewart, S Verma, J A Maroun, et al.
Pageof 372